Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 2,504 shares at an average $378.80 ($948,516)
  7. 4 Option exercise SVP - General Counsel acquired 563 shares (option exercise)
  8. 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 1,214 shares (to pay taxes)
  9. 4 Shares withheld for taxes SVP - General Counsel gave up 969 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 11,557 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 1,938 shares (to pay taxes)
  12. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 27,707 shares (to pay taxes)
  13. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 30,935 shares (to pay taxes)
  14. 4 Open-market sale Director sold 1,600 shares at an average $364.98 ($583,964)
  15. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,104 shares at $365.00 ($1,862,960)
  16. 4 Open-market buy Director bought 300 shares at $352.55 ($105,765)
  17. 4 Option exercise Pres. Diagnostics & Genom acquired 1,989 shares (option exercise)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award President, Protein Sciences acquired 2,490 shares (grant or award)
  20. 4 Option exercise Chief Executive Officer acquired 1,737 shares (option exercise)

Page 9 of 35 · 695 filings